MA31365B1 - Utilisation d'inhibiteurs hdac pour le traitement du melanome - Google Patents
Utilisation d'inhibiteurs hdac pour le traitement du melanomeInfo
- Publication number
- MA31365B1 MA31365B1 MA32330A MA32330A MA31365B1 MA 31365 B1 MA31365 B1 MA 31365B1 MA 32330 A MA32330 A MA 32330A MA 32330 A MA32330 A MA 32330A MA 31365 B1 MA31365 B1 MA 31365B1
- Authority
- MA
- Morocco
- Prior art keywords
- melanoma
- treatment
- pharmaceutically acceptable
- acceptable salt
- hdac inhibitor
- Prior art date
Links
- 239000003276 histone deacetylase inhibitor Substances 0.000 title abstract 4
- 201000001441 melanoma Diseases 0.000 title abstract 4
- 229940121372 histone deacetylase inhibitor Drugs 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'invention concerne l'utilisation d'un inhibiteur hdac, plus spécifiquement, ou d'un sel pharmaceutiquement acceptable de celui-ci pour la fabrication de compositions pharmaceutiques pour le traitement du mélanome ; l'utilisation d'un inhibiteur hdac ou d'un sel pharmaceutiquement acceptable de celui-ci dans le traitement du mélanome ; un procédé de traitement d'animaux à sang chaud, mammifères inclus, particulièrement d'humains, souffrant du mélanome, par administration à l'animal nécessitant un tel traitement d'une dose efficace contre la maladie d'un inhibiteur hdac ou d'un sel pharmaceutiquement acceptable de celui-ci.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91734507P | 2007-05-11 | 2007-05-11 | |
| US93827207P | 2007-05-16 | 2007-05-16 | |
| PCT/US2008/063136 WO2008141114A1 (fr) | 2007-05-11 | 2008-05-09 | Utilisation d'inhibiteurs hdac pour le traitement du mélanome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA31365B1 true MA31365B1 (fr) | 2010-05-03 |
Family
ID=39641895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA32330A MA31365B1 (fr) | 2007-05-11 | 2009-11-09 | Utilisation d'inhibiteurs hdac pour le traitement du melanome |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20110034531A1 (fr) |
| EP (1) | EP2155193A1 (fr) |
| JP (1) | JP2010526830A (fr) |
| KR (1) | KR20100016376A (fr) |
| CN (1) | CN101677995A (fr) |
| AU (1) | AU2008251499A1 (fr) |
| CA (1) | CA2684114A1 (fr) |
| CL (1) | CL2008001363A1 (fr) |
| IL (1) | IL201439A0 (fr) |
| MA (1) | MA31365B1 (fr) |
| MX (1) | MX2009012179A (fr) |
| RU (1) | RU2009145803A (fr) |
| TN (1) | TN2009000449A1 (fr) |
| TW (1) | TW200911231A (fr) |
| WO (1) | WO2008141114A1 (fr) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020354A1 (es) * | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
-
2008
- 2008-05-09 KR KR1020097023399A patent/KR20100016376A/ko not_active Withdrawn
- 2008-05-09 RU RU2009145803/15A patent/RU2009145803A/ru not_active Application Discontinuation
- 2008-05-09 CA CA002684114A patent/CA2684114A1/fr not_active Abandoned
- 2008-05-09 CN CN200880015739A patent/CN101677995A/zh active Pending
- 2008-05-09 WO PCT/US2008/063136 patent/WO2008141114A1/fr not_active Ceased
- 2008-05-09 MX MX2009012179A patent/MX2009012179A/es not_active Application Discontinuation
- 2008-05-09 TW TW097117331A patent/TW200911231A/zh unknown
- 2008-05-09 CL CL2008001363A patent/CL2008001363A1/es unknown
- 2008-05-09 US US12/594,978 patent/US20110034531A1/en not_active Abandoned
- 2008-05-09 JP JP2010507680A patent/JP2010526830A/ja not_active Withdrawn
- 2008-05-09 EP EP08747872A patent/EP2155193A1/fr not_active Withdrawn
- 2008-05-09 AU AU2008251499A patent/AU2008251499A1/en not_active Abandoned
-
2009
- 2009-10-11 IL IL201439A patent/IL201439A0/en unknown
- 2009-10-29 TN TNP2009000449A patent/TN2009000449A1/fr unknown
- 2009-11-09 MA MA32330A patent/MA31365B1/fr unknown
-
2011
- 2011-07-26 US US13/190,764 patent/US20110288144A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20110034531A1 (en) | 2011-02-10 |
| KR20100016376A (ko) | 2010-02-12 |
| JP2010526830A (ja) | 2010-08-05 |
| RU2009145803A (ru) | 2011-06-20 |
| IL201439A0 (en) | 2010-05-31 |
| TN2009000449A1 (en) | 2011-03-31 |
| MX2009012179A (es) | 2009-12-01 |
| US20110288144A1 (en) | 2011-11-24 |
| AU2008251499A1 (en) | 2008-11-20 |
| CA2684114A1 (fr) | 2008-11-20 |
| CL2008001363A1 (es) | 2008-12-19 |
| EP2155193A1 (fr) | 2010-02-24 |
| CN101677995A (zh) | 2010-03-24 |
| WO2008141114A1 (fr) | 2008-11-20 |
| TW200911231A (en) | 2009-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900613A1 (ru) | Спирокетоновые ингибиторы ацетил-коа-карбоксилаз | |
| MX2023007192A (es) | Inhibidores de prmt5. | |
| MX2023009222A (es) | Inhibidores tricíclicos-amido-bicíclicos de prmt5. | |
| MA33467B1 (fr) | Promédicaments comprenant un conjugué insuline-lieur | |
| MA35246B1 (fr) | 1,3-oxazines en tant qu'inhibiteurs de bace1 et/ou de bace2 | |
| UA85702C2 (ru) | 3-[ 4-гетероциклил-1,2,3-триазол-1-ил]-n-арилбензамиды как ингибиторы продуцирования цитокинов, предназначены для лечения хронических воспалительных заболеваний | |
| WO2009039397A3 (fr) | Amides substitués, procédé pour les préparer et procédé pour les utiliser | |
| NO20083568L (no) | Hydantoinforbindelser for behandling av inflammatoriske forstyrrelser | |
| EA201070328A1 (ru) | Соединения триазолопиридина и их применение в качестве ингибиторов ask | |
| EP2178869A4 (fr) | Composés d'indole en tant qu'inhibiteurs de nécrose cellulaire | |
| NZ592425A (en) | Isoindoline compounds for use in the treatment of cancer | |
| EA201101507A1 (ru) | Способы лечения солидных опухолей | |
| WO2009144555A8 (fr) | Inhibiteurs de la pyrazolospirocétone acétyl-coa carboxylase | |
| MA57412B1 (fr) | Benzopyrrole substitués et inhibiteurs du complément structurellement apparentés | |
| EA201490163A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| MA33419B1 (fr) | Composés et compositions pour le traitement de maladies parasitaires | |
| MA31706B1 (fr) | Formulations galéniques de composés organiques | |
| EA201490277A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| MA41238A (fr) | Dérivés 5-[(pipérazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione en tant qu'inhibiteurs d'adamts pour le traitement de l'ostéoarthrit | |
| ATE487720T1 (de) | 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer | |
| EA201001094A1 (ru) | Производные индазола | |
| MA37886B1 (fr) | Nouvelles pyridinones bicycliques | |
| NO20091185L (no) | Piperidinderivater | |
| MA33533B1 (fr) | Compositions pharmaceutiques pour le traitement du cancer et d'autres maladies ou troubles | |
| ATE554084T1 (de) | N-hydroxyacrylamidverbindungen |